Literature DB >> 21984863

Recognizing the musculoskeletal manifestations of vitamin D deficiency.

Andrea N Jones1, Karen E Hansen.   

Abstract

A disruption in any part of the vitamin D physiological pathway can result in vitamin D deficiency, which may lead to bone pain, muscle weakness, falls, low bone mass, and fractures. Recognizing the signs and symptoms helps physicians make a proper diagnosis and prescribe appropriate treatment. Physicians should suspect osteomalacia in patients who have prolonged vitamin D deficiency, a low serum calcium level, or a low serum phosphorus level. Patients with cystic fibrosis are at increased risk for deficiencies in fat-soluble vitamins, including vitamin D. Secondary hyperparathyroidism can develop in patients with chronic kidney disease as a result of low 25-hydroxyvitamin D levels or impaired conversion to 1,25-dihydroxyvitamin D. Patients may experience abnormal vitamin D metabolism as a result of taking anticonvulsants and other medications.

Entities:  

Year:  2009        PMID: 21984863      PMCID: PMC3188408     

Source DB:  PubMed          Journal:  J Musculoskelet Med        ISSN: 0899-2517


  19 in total

1.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

2.  Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.

Authors:  Lourdes Craver; Maria Paz Marco; Isabel Martínez; Montserrat Rue; Merce Borràs; Maria Luisa Martín; Felipe Sarró; José Manuel Valdivielso; Elvira Fernández
Journal:  Nephrol Dial Transplant       Date:  2007-01-05       Impact factor: 5.992

Review 3.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

4.  Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light.

Authors:  Natasha B Khazai; Suzanne E Judd; Leo Jeng; Linda L Wolfenden; Arlene Stecenko; Thomas R Ziegler; Vin Tangpricha
Journal:  J Clin Endocrinol Metab       Date:  2009-03-31       Impact factor: 5.958

5.  Changes in bone mineral density following treatment of osteomalacia.

Authors:  Rajiv Bhambri; Vaishali Naik; Nidhi Malhotra; Shilpa Taneja; Saurabh Rastogi; Uma Ravishanker; Ambrish Mithal
Journal:  J Clin Densitom       Date:  2006-03-27       Impact factor: 2.617

6.  Noninvasive testing in the diagnosis of osteomalacia.

Authors:  C T Bingham; L A Fitzpatrick
Journal:  Am J Med       Date:  1993-11       Impact factor: 4.965

Review 7.  Bone disease associated with antiepileptic drugs.

Authors:  Alison M Pack; Barry Gidal; Blanca Vazquez
Journal:  Cleve Clin J Med       Date:  2004-02       Impact factor: 2.321

8.  A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia.

Authors:  N Collins; J Maher; M Cole; M Baker; N Callaghan
Journal:  Q J Med       Date:  1991-02

Review 9.  Musculoskeletal manifestations of osteomalacia and rickets.

Authors:  Antonio J Reginato; Juliet Arambulo Coquia
Journal:  Best Pract Res Clin Rheumatol       Date:  2003-12       Impact factor: 4.098

10.  Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004.

Authors:  Anne C Looker; Christine M Pfeiffer; David A Lacher; Rosemary L Schleicher; Mary Frances Picciano; Elizabeth A Yetley
Journal:  Am J Clin Nutr       Date:  2008-12       Impact factor: 7.045

View more
  3 in total

1.  Significant association among growing pains, vitamin D supplementation, and bone mineral status: results from a pilot cohort study.

Authors:  Grazia Morandi; E Maines; C Piona; E Monti; M Sandri; R Gaudino; A Boner; F Antoniazzi
Journal:  J Bone Miner Metab       Date:  2014-03-15       Impact factor: 2.626

2.  Association between neurological and rheumatological manifestations in vitamin D deficiency and vitamin D levels.

Authors:  Faiza A Qari; Tariq A Nasser
Journal:  Pak J Med Sci       Date:  2013-05       Impact factor: 1.088

3.  Low serum 25-hydroxyvitamin D level is associated with obesity and atherogenesis in adolescent boys.

Authors:  Junko Naganuma; Satomi Koyama; Osamu Arisaka; Shigemi Yoshihara
Journal:  Ann Pediatr Endocrinol Metab       Date:  2021-10-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.